Resource support of adaptation capabilities of the pharmaceutical industry under COVID-19 pandemic

Authors

  • Natalia Klunko Saint-Petersburg University of Management Technologies and Economics; Autonomous Nonprofit Organization of Higher Education «Russian New University», Russian Federation https://orcid.org/0000-0003-0973-4644

DOI:

https://doi.org/10.15587/2706-5448.2021.230581

Keywords:

pandemic problems, pharmaceutical complex, antiviral strategy, externalization, adaptive capabilities, resource provision model

Abstract

The object of research in this work is the pharmaceutical complex as one of the most important elements of the «antiviral strategy», formed both at the global level and at the level of national states. These strategies are a new direction of management and, as the practice of their implementation shows, the effectiveness of these strategies is low due to the lack of a clear vision of the possibilities of their resource provision. This prevents the pharmaceutical complex from successfully adapting to the current situation.

It is determined that the pharmaceutical industry is currently struggling to address the challenges posed by the COVID-19 pandemic. These problems are associated with a lack of experience in operating in the context of a sharp surge in morbidity and with excessive commercialization of the production of vaccines and antiviral drugs, which gives rise to competition between firms and brands, which in some cases is unfair. And also with an insufficient intellectual component of the pharmaceutical industry, which is manifested in the absence of «breakthrough solutions» and scientific discoveries in this area. These circumstances significantly reduce the ability to counter a pandemic, require appropriate solutions, in particular, the adaptation of the pharmaceutical complex to current conditions.

Through the use of the method of analysis, generalization and classification, the existing resource base of the pharmaceutical industry is considered in the work.

The analysis shows that the «financial resources» and «human capital» of the pharmaceutical industry are currently hardly able to solve the problem of COVID-19. At the moment, the only resource that can really change the situation for the better are organizational resources that allow influencing positive solutions to the indicated problem at the lowest cost and in a relatively short period of time.

The paper provides a list of areas that form the «field of organizational resources», provides the appropriate arguments that allow to recommend them for practical use.

Author Biography

Natalia Klunko, Saint-Petersburg University of Management Technologies and Economics; Autonomous Nonprofit Organization of Higher Education «Russian New University»

PhD, Doctoral Student

Deputy Head of Department

Department of Postgraduate and Doctoral Studies

References

  1. Ares Castro-Conde, B., López Mouriño, V. M., Sanz Falque, I., López Castro, J. (2021). COVID 19 and the new challenges in health management: The pilot experience of the Internal Medicine Department of a Regional hospital. Journal of Healthcare Quality Research, 36 (1), 54–55. doi: http://doi.org/10.1016/j.jhqr.2020.11.001
  2. Nikhat, S., Fazil, M. (2020). Overview of Covid-19; its prevention and management in the light of Unani medicine. Science of The Total Environment, 728, 138859. doi: http://doi.org/10.1016/j.scitotenv.2020.138859
  3. Ballesteros Sanz, M. Á., Hernández-Tejedor, A., Estella, Á., Jiménez Rivera, J. J., González de Molina Ortiz, F. J., Sandiumenge Camps, A. et. al. (2020). Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19). Medicina Intensiva (English Edition), 44 (6), 371–388. doi: http://doi.org/10.1016/j.medine.2020.04.003
  4. Chan, H.-Y., Chen, A., Ma, W., Sze, N.-N., Liu, X. (2021). COVID-19, community response, public policy, and travel patterns: A tale of Hong Kong. Transport Policy, 106, 173–184. doi: http://doi.org/10.1016/j.tranpol.2021.04.002
  5. Sarkar, A., Liu, G., Jin, Y., Xie, Z., Zheng, Z.-J. (2020). Public health preparedness and responses to the coronavirus disease 2019 (COVID-19) pandemic in South Asia: a situation and policy analysis. Global Health Journal, 4 (4), 121–132. doi: http://doi.org/10.1016/j.glohj.2020.11.003
  6. Lv, N., Sun, M., Polonowita, A., Mei, L., Guan, G. (2021). Management of oral medicine emergencies during COVID-19: A study to develop practise guidelines. Journal of Dental Sciences, 16 (1), 493–500. doi: http://doi.org/10.1016/j.jds.2020.07.016
  7. Cutler, D. M., Summers, L. H. (2020). The COVID-19 Pandemic and the $16 Trillion Virus. JAMA, 324 (15), 1495–1496. doi: http://doi.org/10.1001/jama.2020.19759
  8. Coughlin, S. S., Yiǧiter, A., Xu, H., Berman, A. E., Chen, J. (2020). Early detection of change patterns in COVID-19 incidence and the implementation of public health policies: a multi-national study. Public Health in Practice, 100064. doi: http://doi.org/10.1016/j.puhip.2020.100064
  9. Sokolova, L. V. (2016). The Theoretical and Methodological Platform for Developing a System of Enterprise Adaptation to Changes in the External Environment. The problems of economy, 3, 206–212.
  10. Kryvobok, K. V. (2020). Managing the processes of adaptation of the industrial enterprise the external environment. Kharkiv, 291.
  11. Turylo, A. M., Bogachevska, K. V. (2014). Theoretical and methodical frame work for determining the essence of the economic category "enterprise potential for adaptation". Аctual problems of economics, 2 (152), 26–32.
  12. Tonini, Dzh. (2020). Neschaste pomoglo: uchenye, mediki i predprinimateli, stavshie milliarderami blagodarya COVID-19. Available at: https://www.forbes.ru/milliardery/417235-neschaste-pomoglo-uchenye-mediki-i-predprinimateli-stavshie-milliarderami
  13. Overchenko, M. (2020). Na kakie aktsii polozhitelno povliyala epidemiya koronavirusa. Available at: https://www.vedomosti.ru/finance/articles/2020/03/07/824697-aktsii-polozhitelno-koronavirusa
  14. Spisok laureatov Nobelevskoy premii. Available at: https://ru.wikipedia.org/wiki/Список_лауреатов_Нобелевской_премии_мира
  15. Robarge-Silkiner, S. A. Introduction to the Strategic National Stockpile. Available at: http://www.kdheks.gov/cphp/download/Intro_SNS.pdf

Downloads

Published

2021-04-30

How to Cite

Klunko, N. (2021). Resource support of adaptation capabilities of the pharmaceutical industry under COVID-19 pandemic. Technology Audit and Production Reserves, 2(4(58), 6–11. https://doi.org/10.15587/2706-5448.2021.230581

Issue

Vol. 2 No. 4(58) (2021): Economics of enterprises. Macroeconomics

Section

Economics and Enterprise Management: Original Research

License

Copyright (c) 2021 Natalia Klunko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The consolidation and conditions for the transfer of copyright (identification of authorship) is carried out in the License Agreement. In particular, the authors reserve the right to the authorship of their manuscript and transfer the first publication of this work to the journal under the terms of the Creative Commons CC BY license. At the same time, they have the right to conclude on their own additional agreements concerning the non-exclusive distribution of the work in the form in which it was published by this journal, but provided that the link to the first publication of the article in this journal is preserved.